<?xml version="1.0" encoding="UTF-8"?>
<ref id="B87-vaccines-08-00098">
 <label>87.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Di Gaetano</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Cittera</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Nota</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Vecchi</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Grieco</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Scanziani</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Botto</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Introna</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Golay</surname>
    <given-names>J.</given-names>
   </name>
  </person-group>
  <article-title>Complement activation determines the therapeutic activity of rituximab in vivo</article-title>
  <source>J. Immunol.</source>
  <year>2003</year>
  <volume>171</volume>
  <fpage>1581</fpage>
  <lpage>1587</lpage>
  <pub-id pub-id-type="doi">10.4049/jimmunol.171.3.1581</pub-id>
  <pub-id pub-id-type="pmid">12874252</pub-id>
 </element-citation>
</ref>
